Get started
Intercept Pharmaceuticals, Inc. 3.5% 15-FEB-2026Intercept Pharmaceuticals, Inc. 3.5% 15-FEB-2026Intercept Pharmaceuticals, Inc. 3.5% 15-FEB-2026

Intercept Pharmaceuticals, Inc. 3.5% 15-FEB-2026

No trades
See on Supercharts
Overview
Analysis

ICPT5464611 chart


Full chart

Key terms


Outstanding amount
‪60.00 K‬ USD
Face value
1,000.00 USD
Minimum denomination
1,000.00 USD
Coupon
3.50% (Fixed)
Coupon frequency
Semi-annual
Yield to maturity
0.08%
Maturity date
Feb 15, 2026
Term to maturity
1 year

About Intercept Pharmaceuticals, Inc. 3.5% 15-FEB-2026


Issuer
Intercept Pharmaceuticals, Inc.
Sector
Health Technology
Home page
interceptpharma.com
Issue date
Aug 18, 2022
FIGI
BBG01239DFQ5
Intercept Pharmaceuticals is a biopharmaceutical company, that engages in discovering and developing small molecule drugs and therapeutics for the treatment of chronic fibrotic and metabolic diseases. It offers INT-747, an FXR modulating agent that treats patients with chronic autoimmune liver diseases. The company's drug development programs also focus on modulating bile acid receptors, and amelioration of metabolic and hepatic functions in chronic liver diseases

ICPT5464611 analysis


Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.